BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,706,000 | -49.2% | 170,787 | -2.7% | 0.10% | -66.3% |
| Q3 2021 | $3,355,000 | -30.6% | 175,587 | +16.1% | 0.30% | -39.8% |
| Q2 2021 | $4,835,000 | -8.5% | 151,173 | -13.7% | 0.50% | -6.6% |
| Q1 2021 | $5,282,000 | -65.4% | 175,178 | -38.1% | 0.53% | -72.4% |
| Q3 2020 | $15,273,000 | +93.0% | 283,087 | +118.4% | 1.93% | 0.0% |
| Q2 2020 | $7,912,000 | – | 129,622 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
| RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
| APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
| Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
| Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
| RA Capital Management | 167,367 | $14,318,000 | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
| Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
| Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
| CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |